BRIEF-Merrimack stockholders approve Onivyde, generic Doxil sale to Ipsen

* Merrimack stockholders approve sale of Onivyde and generic version of Doxil to Ipsen for up to $1.025 billion
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.